CPHD Share Price

Open 52.95 Change Price %
High 53.00 1 Day 0.00 0.00
Low 52.95 1 Week 0.00 0.00
Close 52.95 1 Month 0.00 0.00
Volume 2651121 1 Year 20.23 61.83
52 Week High 53.91
52 Week Low 25.09
CPHD Important Levels
Resistance 2 53.00
Resistance 1 52.98
Pivot 52.97
Support 1 52.92
Support 2 52.90
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
APRI 2.86 89.40%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
APRI 2.86 89.40%
AMCF 0.06 50.00%
LOCM 0.09 50.00%
SKBI 0.12 50.00%
UNXL 1.69 34.13%
LIFE 3.25 32.65%
CHCI 2.42 29.41%
GLBS 6.17 27.22%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
THTI 0.15 -40.00%
More..

CEPHEID (NASDAQ: CPHD)

CPHD Technical Analysis 5
As on 4th Nov 2016 CPHD Share Price closed @ 52.95 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 35.92 & Strong Buy for SHORT-TERM with Stoploss of 49.16 we also expect STOCK to react on Following IMPORTANT LEVELS.
CPHD Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
CPHD Other Details
Segment EQ
Market Capital 2057364736.00
Sector Technology
Industry Scientific & Technical Instruments
Offical website http://www.cepheid.com
CPHD Address
CPHD
904 Caribbean Drive
Sunnyvale, CA 94089
United States
Phone: 408-541-4191
Fax: 408-541-4192
CPHD Latest News
Cepheid (CPHD) Shares Sold by Kornitzer Capital Management Inc. KS   Community Financial News   - 17th Jan 17
Wall Street and Armchair Analysts Weigh in on CEPHEID (NASDAQ:CPHD) Heading ...   Wall Street Beacon   - 17th Jan 17
Cepheid Receives FDA Clearance for MRSA MDx   GenomeWeb   - 19th Dec 16
Danaher Completes Acquisition Of Cepheid   PR Newswire (press release)   - 05th Nov 16
Cepheid Announces Receipt of Required Regulatory Clearances in Proposed ...   PR Newswire (press release)   - 24th Oct 16
Cepheid: Commercial Launch of Xpert Bladder Cancer Monitor   Yahoo Finance   - 10th Oct 16
CEPHEID SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation ...   PR Newswire (press release)   - 10th Sep 16
Cepheid Targets Development of a Point of Care HIV Viral Load Test From a Few ...   PR Newswire (press release)   - 09th Sep 16
Danaher to buy Cepheid for about $4 billion, including debt   CNBC   - 06th Sep 16
Cepheid Announces Appointment of President and Chief Operating Officer and ...   PR Newswire (press release)   - 11th Feb 16
Interactive Technical Analysis Chart CEPHEID ( CPHD NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on CEPHEID
CPHD Business Profile
Cepheid is a molecular diagnostics company that develops, manufactures and markets fully-integrated systems for testing in the Clinical market, as well as for application in its legacy Non-Clinical market. The Company�s systems enable rapid, sophisticated molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company�s two principal systems are the GeneXpert and SmartCycler. The GeneXpert system, its primary offering in the Clinical market, integrates sample preparation in addition to DNA amplification and detection. The GeneXpert system is designed for a broad range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals and doctors� offices. The SmartCycler system integrates DNA amplification and detection to allow rapid analysis of a sample.